TheraCryf PLC (TCF)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.20p
Buy
0.22p
0.00p (+0.00%)
Prices updated at 11 Dec 2025, 14:50 GMT
| Prices minimum 15 mins delay
Prices in GBX
Evgen Pharma PLC is a clinical stage drug development company focused on cancer and neurological disease. Its pipeline is based on Sulforadex technology which includes synthetic and stabilized analogues of sulforaphane.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
03 Dec 202526 Nov 202524 Nov 202503 Nov 202516 Oct 202516 Oct 202510 Oct 202526 Sep 202508 Sep 202504 Sep 2025
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Dec 2026 |
| Annual general meeting | Jul 2026 |
| Annual report | Jun 2026 |
| Final results | Jun 2026 |
| Previous date | |
|---|---|
| Half yearly results | Dec 2025 |
| Annual general meeting | Jul 2025 |
| Annual report | Jun 2025 |
| Final results | Jun 2025 |
Company reports
31 Mar 2023
Annual Report 30 Sep 2025
Quarterly Report 